Rosemina Merchant
Founder at MEDICENNA THERAPEUTICS CORP.
Net worth: 7 M $ as of 2024-03-30
Profile
Rosemina Merchant was the founder of Intelligene Expressions, Inc. (founded in 1992) where she held the title of Chief Operating Officer & VP-Manufacturing from 1992 to 2002.
She is also the founder of Medicenna Therapeutics, Inc. (founded in 2011) where she currently holds the title of Director.
Additionally, she is the founder of Medicenna Therapeutics Corp.
(founded in 2011) where she currently holds the title of Chief Development Officer.
Ms. Merchant's current job is as Vice President-International Regulatory Affairs at Intelligenetics, Inc. (since 2001).
Her former job was as Vice President-Regulatory Affairs & Development at Sophiris Bio, Inc. (from 2004 to 2013).
Merchant has a graduate degree from the University of Western Ontario and an undergraduate degree from the University of Aston.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-30 | 5,300,700 ( 7.61% ) | 7 M $ | 2024-03-30 |
Rosemina Merchant active positions
Companies | Position | Start |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Founder | 2011-09-30 |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | General Counsel | 2000-12-31 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Founder | 2011-10-29 |
Former positions of Rosemina Merchant
Companies | Position | End |
---|---|---|
SOPHIRIS BIO | General Counsel | 2012-12-31 |
Intelligene Expressions, Inc. | Founder | 2001-12-31 |
Training of Rosemina Merchant
University of Western Ontario | Graduate Degree |
University of Aston | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Private companies | 4 |
---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | Technology Services |
Intelligene Expressions, Inc. | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
- Stock Market
- Insiders
- Rosemina Merchant